The effects of rapamycin on lens epithelial cell proliferation, migration, and matrix formation: An in vitro study

Molecular Vision

Volumn 16, Issue , 2010, Pages 1646-1653

  Liu, Hongling ^a   Feng, Guangzhong ^a   Wu, Lan ^b   Fu, Shaoying ^a   Liu, Ping ^a   Yang, Wei ^a   Zhang, Xiaomei ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Daqing Field Genaral Hospithal   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYCLINE; FIBRONECTIN; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CATARACT; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; EXTRACELLULAR MATRIX; LENS EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RABBIT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; LENS, CRYSTALLINE; PROLIFERATING CELL NUCLEAR ANTIGEN; RABBITS; SIROLIMUS;

EID: 77956962424     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Apple DJ, Solomon KD, Tetz MR, Assia EI, Holland EY, Legler UF, Tsai JC, Castaneda VE, Hoggatt JP, Kostick AM. Posterior capsule opacification. Surv Ophthalmol 1992; 37:73-116.
2. McDonnell PJ, Zarbin MA, Green WR. Posterior capsule opacification in pseudophakic eyes. Ophthalmology 1983; 90:1548-1553.
3. Meacock WR, Spalton DJ, Stanford MR. Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol 2000; 84:332-336.
4. Saika S, Ohmi S, Kanagawa R, Tanaka S, Ohnishi Y, Ooshima A, Yamanaka A. Lens epithelial cell outgrowth and matrix formation on intraocular lenses in rabbit eyes. J Cataract Refract Surg 1996; 22:835-840.
5. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349:1315-1323.
6. Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky R, Klugherz BD, Papandreou G, Narayan P, Leon MB, Yeung AC, Tio F, Tsao PS, Falotico R, Carter AJ. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104:1188-1193.
7. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 1996; 98:2277-2283.
8. Liu H, Wu L, Fu S, Hou Y, Liu P, Cui H, Liu J, Xing L, Zhang X. Polylactide-glycoli acid and rapamycin coating intraocular lens prevent posterior capsular opacification in rabbit eyes. Graefes Arch Clin Exp Ophthalmol 2009; 247:801-807.
9. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
10. Xie L, Sun J, Yao Z. Heparin drug delivery system for prevention of posterior capsular opacification in rabbit eyes. Graefes Arch Clin Exp Ophthalmol 2003; 241:309-313.
11. Finkelstein A, McClean D, Kar S, Takizawa K, Varghese K, Baek N, Park K, Fishbein MC, Makkar R, Litvack F, Eigler NL. Local drug delivery via a coronary stent with programmable release pharmacokinetics. Circulation 2003; 107:777-784.
12. Ibaraki N, Lin LR, Reddy VN. Effects of growth factors on proliferation and differentiation in human lens epithelial cells in early subculture. Invest Ophthalmol Vis Sci 1995; 36:2304-2312.
13. Wunderlich K, Knorr M. Effect of platelet-derived growth factor PDGF on replication of cultivated bovine lens epithelial cells. Ophthalmologe 1994; 91:98-102.
14. Kwon YS, Kim JC. Inhibition of corneal neovascularization by rapamycin. Exp Mol Med 2006; 38:173-179.
15. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 1996; 98:2277-2283.
16. Parmigiani C, McAvoy J. Localisation of laminin and fibronectin during rat lens morphogenesis. Differentiation 1984; 28:53-61.
17. Cammarata PR, Cantu-Crouch D, Oakford L, Morrill A. Macromolecular organization of bovine lens capsule. Tissue Cell 1986; 18:83-97.
18. Marshall GE, Konstas AG, Bechrakis NE, Lee WR. An immunoelectron microscope study of the aged human lens capsule. Exp Eye Res 1992; 54:393-401.
19. Majo F, Montard M, Delbosc B, Kantelip B. Immunolabelling of collagen types I, III and IV, laminin and fibronectin in the human lens capsule. J Fr Ophtalmol 1997; 20:664-670.
20. Zelenka PS. Regulation of cell adhesion and migration in lens development. Int J Dev Biol 2004; 48:857-865.
21. Cammarata PR, Spiro RG. Identification of noncollagenous components of calf lens capsule: evaluation of their adhesionpromoting activity. J Cell Physiol 1985; 125:393-402.
22. Cammarata PR, Spiro RG. Lens epithelial cell adhesion to lens capsule: a model system for cell-basement membrane model system for cell-basement membrane interaction. J Cell Physiol 1982; 113:273-280.
23. Taliana L, Evans MD, Ang S, McAvoy JW. Vitronectin is present in epithelial cells of the intact lens and promotes epithelial mesenchymal transition in lens epithelial explants. Mol Vis 2006; 12:1233-1242.
24. McCarthy JB, Hagen ST, Furcht LT. Human fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells. J Cell Biol 1986; 102:179-188.
25. Herbst TJ, McCarthy JB, Tsilibary EC, Furcht LT. Differential effects of laminin, intact type IV collagen, and specific domains of type IV collagen on endothelial cell adhesion and migration. J Cell Biol 1988; 106:1365-1373.